Простой график
Расширенный график
Описание Tema Obesity & Cardiometabolic ETF
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
| Цена последней сделки |
33.86 |
| Код ценной бумаги |
HRTS |
| Полное наименование |
Tema Obesity & Cardiometabolic ETF |
| Объем |
59531088.00 |
| Валюта |
usd |
| Изм за день, % |
-0.01 |
| Комиссия |
0.75 |
| Дата основания |
Nov 21. 2023 |
| Сайт |
cсылка
|
| Тип актива |
Equity |
| Индекс |
ACTIVE - No Index |
| Регион |
Global |
| Средний P/E |
16.57 |
| Issuer |
Dawn Global Topco Ltd. |
| Assets class size |
Multi-Cap |
| Region specific |
Broad |
| Strategy |
Active |
| Focus |
Health Care |
| Segment |
Equity: Global Pharma, Biotech & Life Sciences |
| country |
USA |
| countryISO |
US |
| Количество компаний |
10 |
| Изменение цены за день: |
-0.4703% (34.02) |
| Изменение цены за неделю: |
-2.2% (34.62) |
| Изменение цены за месяц: |
-3.48% (35.08) |
| Изменение цены за 3 месяца: |
+1.0445% (33.51) |
| Изменение цены за полгода: |
-0.9362% (34.18) |
| Изменение цены с начала года: |
+10.62% (30.61) |
| Название |
Отрасль |
Доля, % |
P/BV |
P/S |
P/E |
EV/Ebitda |
Дивидендная доходность |
|
|
|
|
|
|
|
|
